74.57
1.17%
-0.88
Vaxcyte Inc Borsa (PCVX) Ultime notizie
Natixis Advisors L.P. Acquires Shares of 14035 Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
Defense World
Truist Financial Corp Boosts Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
Defense World
Is Vaxcyte Inc (PCVX) a good investment opportunity? – US Post News - US Post News
US Post News
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by Amalgamated Bank - Defense World
Defense World
Natixis Advisors L.P. Invests $881,000 in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
MarketBeat
Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update - br.ADVFN.com
br.ADVFN.com
Vaxcyte (NASDAQ:PCVX) Trading 5.5% Higher - MarketBeat
MarketBeat
Vaxcyte Inc (PCVX) Stock: Navigating a Year of Volatility - The InvestChronicle
The InvestChronicle
Wall Street Analysts Think Vaxcyte, Inc. (PCVX) Could Surge 33.33%: Read This Before Placing a Bet - Yahoo News Australia
Yahoo News Australia
Nicholas Investment Partners LP Trims Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
MarketBeat
Keeping an Eye on Vaxcyte Inc (PCVX) After Insider Trading Activity – Knox Daily - Knox Daily
Knox Daily
Q2 2024 EPS Estimates for Vaxcyte, Inc. Lowered by Leerink Partnrs (NASDAQ:PCVX) - MarketBeat
MarketBeat
(PCVX) Investment Report - Stock Traders Daily
Stock Traders Daily
Vaxcyte (NASDAQ:PCVX) Stock Rating Reaffirmed by Needham & Company LLC - Defense World
Defense World
Wall Street Analysts Think Vaxcyte, Inc. (PCVX) Could Surge 33.33%: Read This Before Placing a Bet - Yahoo News Australia
Yahoo News Australia
Wall Street Analysts Think Vaxcyte, Inc. (PCVX) Could Surge 33.33%: Read This Before Placing a Bet - Yahoo News Australia
Yahoo News Australia
Vaxcyte (NASDAQ:PCVX) Has Debt But No Earnings; Should You Worry? - Simply Wall St
Simply Wall St
Vaxcyte (NASDAQ:PCVX) Receives "Overweight" Rating from Cantor Fitzgerald - MarketBeat
MarketBeat
Vaxcyte (NASDAQ:PCVX) Posts Quarterly Earnings Results, Beats Estimates By $0.28 EPS - MarketBeat
MarketBeat
Victory Capital Management Inc. Sells 51542 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
Defense World
Victory Capital Management Inc. Sells 51,542 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat
MarketBeat
Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
GlobeNewswire
Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
GlobeNewswire
Ready to Jump After Recent Trade: Vaxcyte Inc (PCVX) – Sete News - SETE News
SETE News
Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by New York State Common Retirement Fund - Defense World
Defense World
California Public Employees Retirement System Cuts Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
Defense World
Vaxcyte COO sells over $184k in company stock - Investing.com Canada
Investing.com Canada
Insider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) CEO Sells 15000 Shares of Stock - Defense World
Defense World
Vaxcyte CEO sells $928,845 in stock, buys $26,850 worth By Investing.com - Investing.com
Investing.com
(PCVX) Trading Report - Stock Traders Daily
Stock Traders Daily
Insider Selling: Wassil Jim, Vaxcyte Inc [PCVX] CHIEF OPERATING OFFICER divested 3000 shares – Knox Daily - Knox Daily
Knox Daily
Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says
Benzinga
Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says - Vaxcyte (NA - Benzinga
Benzinga
Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst - Seeking Alpha
Seeking Alpha
Vaxcyte CEO sells over $174k in company stock - Investing.com
Investing.com
Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire Inc.
Insider Sell: Vaxcyte Inc (PCVX) CFO Andrew Guggenhime Sells 8,000 Shares - Yahoo Finance
Yahoo Finance
Oracle To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday
Benzinga
Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants
GlobeNewswire Inc.
Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal ... - Yahoo Finance
Yahoo Finance
PCVX Stock Quote Price and Forecast - CNN
CNN
Vaxcyte, Inc. (PCVX) Is Up 2.14% in One Week: What You Should Know
Zacks Investment Research
Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcript - Yahoo Finance
Yahoo Finance
Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire Inc.
The Zacks Analyst Blog Highlights HEICO, Constellation Energy, Inter Parfums, Apellis Pharmaceuticals and Vaxcyte
Zacks Investment Research
Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - Yahoo Finance
Yahoo Finance
Why Vaxcyte (PCVX) Might Surprise This Earnings Season
Zacks Investment Research
5 Stocks to Buy That Are Poised to Beat on Earnings This Week
Zacks Investment Research
5 Best Russell 2000 Stocks To Buy According To Hedge Funds - Insider Monkey
Insider Monkey
Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
GlobeNewswire Inc.
Capitalizzazione:
|
Volume (24 ore):